Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
immunology and microbiology
Introduction of SARS-CoV-2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil
Journal of Medical Virology, Volume 94, No. 3, Year 2022
Notification
URL copied to clipboard!
Description
The Lambda variants of interest (VOI) (C37/GR/452Q.V1/21G) was initially reported in Lima, Peru but has gained rapid dissemination through other Latin American countries. Nevertheless, the dissemination and molecular epidemiology of the Lambda VOI in Brazil is unknown apart from a single case report. In this respect, we characterized the circulation of the SARS-CoV-2 Lambda VOI (C37/GR/452Q.V1/21G) in Sao Paulo State, Brazil. From March to June 2021, we identified seven Lambda isolates in a set of approximately 8000 newly sequenced genomes of the Network for Pandemic Alert of Emerging SARS-CoV-2 variants from Sao Paulo State. Interestingly, in three of the positive patients, the Lambda VOI infection was probably related to a contact transmission. These individuals were fully vaccinated to COVID-19 and presented mild symptoms. The remaining positive for Lambda VOI individuals showed different levels of COVID-19 symptoms and one of them needed hospitalization (score 5, WHO). In our study, we present a low level of Lambda VOI circulation in the Sao Paulo State. This reinforces the essential role of molecular surveillance for the effective SARS-CoV-2 pandemic response, especially in regard to circulating variants. © 2021 Wiley Periodicals LLC
Authors & Co-Authors
Haddad, Simone Kashima
Brazil, Sao Paulo
Universidade de São Paulo
Slavov, Svetoslav Nanev
Brazil, Sao Paulo
Universidade de São Paulo
Brazil, Sao Paulo
Instituto Butantan
Giovanetti, Marta
Brazil, Belo Horizonte
Universidade Federal de Minas Gerais
Brazil, Rio de Janeiro
Fundacao Oswaldo Cruz
Rodrigues, Evandra Strazza
Brazil, Sao Paulo
Universidade de São Paulo
Patané, José Salvatore Leister
Brazil, Sao Paulo
Instituto Butantan
Viala, Vincent Louis
Brazil, Sao Paulo
Instituto Butantan
Santos, Elaine Vieira
Brazil, Sao Paulo
Universidade de São Paulo
Evaristo, Mariane
Brazil, Sao Paulo
Universidade de São Paulo
Martins, Antonio Jorge
Brazil, Sao Paulo
Instituto Butantan
Marqueze, Elaine Cristina
Brazil, Sao Paulo
Instituto Butantan
Brassaloti, Ricardo Augusto
Brazil, Sao Paulo
Universidade de São Paulo
Mariani, Pilar Drummond Sampaio Corrêa
Brazil, Piracicaba
Ngs Soluções Genômicas
Kitajima, João Paulo Fumio Whitaker
Brazil, Sao Paulo
Mendelics Análise Genômica
Schlesinger, David J.
Brazil, Sao Paulo
Mendelics Análise Genômica
Bezerra, Rafael Dos Santos
Brazil, Sao Paulo
Universidade de São Paulo
Assato, Patricia Akemi
Brazil, Sao Paulo
Universidade Estadual Paulista Júlio de Mesquita Filho
Poleti, Mirele Daiana
Brazil, Sao Paulo
Universidade de São Paulo
Lesbon, Jéssika Cristina Chagas
Brazil, Sao Paulo
Universidade de São Paulo
Mattos, Elisângela Chicaroni De
Brazil, Sao Paulo
Universidade de São Paulo
Artico Banho, Cecília Artico
Brazil, Sao Jose do Rio Preto
Faculdade de Medicina de São José do Rio Preto
Sacchetto, Lívia
Brazil, Sao Jose do Rio Preto
Faculdade de Medicina de São José do Rio Preto
Grotto, Rejane Maria Tommasini
Brazil, Sao Paulo
Universidade Estadual Paulista Júlio de Mesquita Filho
Souza-Neto, Jayme A.
Brazil, Sao Paulo
Universidade Estadual Paulista Júlio de Mesquita Filho
Fonseca, Vagner S.
Brazil, Belo Horizonte
Universidade Federal de Minas Gerais
Brazil, Brasilia
Ministério da Saúde
de Alcantara, Luiz Carlos Junior
Brazil, Belo Horizonte
Universidade Federal de Minas Gerais
Brazil, Rio de Janeiro
Fundacao Oswaldo Cruz
Nogueira, Mauricio L.
Brazil, Sao Jose do Rio Preto
Faculdade de Medicina de São José do Rio Preto
Fukumasu, H.
Brazil, Sao Paulo
Universidade de São Paulo
Coutinho, Luiz Lehmann
Brazil, Sao Paulo
Universidade de São Paulo
Calado, Rodrigo T.
Brazil, Sao Paulo
Universidade de São Paulo
Elias, Maria Carolina Quartim B.
Brazil, Sao Paulo
Instituto Butantan
Coccuzzo Sampaio, Sandra Coccuzzo
Brazil, Sao Paulo
Instituto Butantan
Covas, Dimas Tadeu
Brazil, Sao Paulo
Universidade de São Paulo
Brazil, Sao Paulo
Instituto Butantan
Statistics
Citations: 5
Authors: 32
Affiliations: 9
Identifiers
Doi:
10.1002/jmv.27389
ISSN:
01466615
Research Areas
Covid
Study Design
Case Study